Skip to main content
. 2014 Jul 3;25(3):249–259. doi: 10.3802/jgo.2014.25.3.249

Table 1.

Molecular pathways targeted in cervical cancer

graphic file with name jgo-25-249-i001.jpg

EGFR, epidermal growth factor receptor; HDAC, histone deacetylase; Her2, human epidermal growth factor receptor 2; HSP, heat shock protein; mTOR, mammalian target or rapamycin; PARP, poly-ADP ribose polymerase; Wee1, nuclear kinase belonging to serine/threonine family of protein kinases.

*Clinical trial reference number for HSP inhibitor in cervical cancer.